Berita Valas

Swiss Market Ends On Firm Note

After opening weak and moving along the unchanged line till about mid afternoon, the Switzerland market began edging up on Monday to eventually end the day's session notably higher.
RTTNews | 662 days ago
Major European Markets Close Higher On Late Buying

Major European Markets Close Higher On Late Buying

Despite struggling for direction during much of the trading session, the major European markets closed higher on Monday as stocks found support past mid afternoon amid optimism the central banks will soon start reducing interest rates.
RTTNews | 662 days ago
Popular Promotes Jorge Garcia To Succeed Carlos Vazquez As CFO

Popular Promotes Jorge Garcia To Succeed Carlos Vazquez As CFO

Popular, Inc. (BPOP) announced Monday that Carlos Vazquez will retire effective March 31, 2024 after serving as Chief Financial Officer since 2013, and in other senior leadership positions since joining Popular in 1997. He will be succeeded by Jorge Garcia, currently Corporate Comptroller and Chief Accounting Officer.
RTTNews | 662 days ago
more news
Bay Street Likely Seen Opening On Subdued Note

Bay Street Likely Seen Opening On Subdued Note

Canadian shares look headed for a muted start Monday morning, amid a lack of positive triggers. With several central banks, including the Federal Reserve, scheduled to announce their monetary policy decisions this week, the mood is likely to remain cautious.
RTTNews | 662 days ago
Orchard Therapeutics Gets Swissmedic Approval For Libmeldy In Early-onset MLD

Orchard Therapeutics Gets Swissmedic Approval For Libmeldy In Early-onset MLD

Gene therapy leader Orchard Therapeutics plc (ORTX) announced Monday the Swiss Agency for Therapeutic Products (Swissmedic) has approved Libmeldy (atidarsagene autotemcel), a hematopoietic stem cell (HSC) gene therapy, for the treatment of early-onset metachromatic leukodystrophy (MLD).
RTTNews | 662 days ago

Stay up to date!

Add Berita to your browser

Extension Picture